Healthcare

Three major insurers have pulled out of the Affordable Care Act's healthcare exchanges, prompting concerns about the exchanges’ long-term sustainability. Yale’s Fiona Scott Morton and Howard Forman discuss the state of Obamacare and what it needs to thrive.

Yale’s Zack Cooper discusses new findings on what drives the high costs of healthcare and how to rein them in.

Dr. Michael Apkon ’02, president and CEO of Toronto’s Hospital for Sick Children, on his role and the hospital’s global approach.

Christopher Ross ’88, chief information officer for Mayo Clinic, discusses trends in the industry and how Mayo is revamping its own technology.

A combination of community motivation and subsidies targeted to the poor is the most effective way to increase toilet ownership and use, and decrease open defecation, in developing countries, according to a new study published in the journal Science.

Healthcare is an industry as much as a science. Innovations that enable the system to deliver better quality at a lower cost are as likely to come from IT, business processes, and design as from new medicines. Moving medicine fully into the digital world could be the linchpin of a more integrated, coordinated approach, if the technology can mesh neatly with the needs of patients, providers, and payers; existing business models; and the complexity of medicine itself.

Electronic medical records and big data have huge promise for improving medicine, but creating a system that works for physicians is a daunting task. By starting with a single specialty—dermatology—Modernizing Medicine has created an electronic application that allows doctors to rapidly enter clinical information, and to draw on the data gathered from thousands of others doing the same. Co-founder Dr. Michael Sherling ’02 discussed the endeavor and how it fits into broader efforts to mesh incentives, incorporate technology, and execute effective change.

Children are 30% more likely to take a stimulant medication during the school year than they are to take one during the summer, according to a new study published in the American Sociological Review. The authors found that school-year increases in stimulant use are largest for children from socioeconomically advantaged families. Because many children use stimulants only during the school year and take a “drug holiday” in the summer, the authors conclude that these children are using stimulants to manage their schools’ academic demands.

The state of global health is never static. The past century has seen some of the greatest advances in life expectancy and overall health in human history. And yet huge disparities exist between rich and poor nations in measures such as infant mortality and life expectancy. Richard Skolnik, a global health expert, talks about how to use the data to inform better decision-making—and to save lives.

As patents on the blockbuster drugs of the 1990s expire, the pharmaceutical industry is facing—not for the first time—questions about the sustainability of its economic model. Clive Meanwell, CEO of The Medicines Company, says that the industry can help patients and make money by changing the nature of its relationship to the healthcare system.